ELAVL1 and endometrial cancer: RT-qPCR and Western blotting results similarly demonstrated a significant enhancement of ELAVL1 expression in endometrial cancer cell lines (HEC-1A, Ishikawa, RL95–2, HEC-1B, and AN3CA) compared to ESC cells (Figure 1b, p < .05).